Rilpivirine

Janessa M. Smith, PharmD, BCPS, Paul Pham, Pharm.D.
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID
Rilpivirine is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

Rilpivirine in combination with other ARVs is indicated for the treatment of HIV-1 infection in ART-naïve patients with HIV-1 RNA < 100,000 copies/mL.

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

Rilpivirine in combination with other ARVs is indicated for the treatment of HIV-1 infection in ART-naïve patients with HIV-1 RNA < 100,000 copies/mL.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: April 8, 2019